• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

50-90 岁年龄组的蜱传脑炎疫苗接种者抗体效价和加强反应降低。

Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years.

机构信息

Institute for Biomedical Aging Research, Austrian Academy of Sciences, Rennweg 10, 6020 Innsbruck, Austria.

出版信息

Vaccine. 2010 Apr 30;28(20):3511-5. doi: 10.1016/j.vaccine.2010.03.024. Epub 2010 Mar 21.

DOI:10.1016/j.vaccine.2010.03.024
PMID:20332047
Abstract

Because of decreased immune functions of older people booster intervals of 3 years - instead of 5 - are recommended for tick-borne encephalitis (TBE) vaccinations for persons >or=60 years in Austria. So far, no comparative data on the immune-responsiveness of the age group 50-59 years are available. We therefore investigated the antibody titers and booster responses (in ELISA and neutralization assays) for the age groups 50-59, 60-69, and >69 years in comparison to a control group below 30 years. The age group 50-59 years displayed the same decreased antibody response, also characteristic for persons 60 years and older. Although antibody concentrations were lower after 5-7 years compared to 3-4 year intervals, antibodies were still detectable and could be sufficiently increased by booster shots in the vast majority of persons. Our results clearly indicate that the responsiveness of the immune system to vaccination is already impaired at the age of 50.

摘要

由于老年人的免疫功能下降,奥地利建议 >or=60 岁的人接种蜱传脑炎(TBE)疫苗的加强针间隔为 3 年,而非 5 年。到目前为止,对于 50-59 岁年龄组的免疫反应性,尚无比较数据。因此,我们调查了 50-59 岁、60-69 岁和 >69 岁年龄组与 30 岁以下对照组的抗体滴度和加强针反应(ELISA 和中和试验)。50-59 岁年龄组的抗体反应与 60 岁及以上人群的特征相同,也呈下降趋势。尽管与 3-4 年的间隔相比,5-7 年后的抗体浓度较低,但在绝大多数人身上,抗体仍然可以检测到,并可通过加强针充分增加。我们的研究结果清楚地表明,免疫系统对疫苗接种的反应性在 50 岁时已经受损。

相似文献

1
Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years.50-90 岁年龄组的蜱传脑炎疫苗接种者抗体效价和加强反应降低。
Vaccine. 2010 Apr 30;28(20):3511-5. doi: 10.1016/j.vaccine.2010.03.024. Epub 2010 Mar 21.
2
Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.老年人对蜱传脑炎(TBE)疫苗接种的血清学反应——一项观察性研究的结果
Expert Opin Biol Ther. 2009 Jul;9(7):797-803. doi: 10.1517/14712590903066711.
3
Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.成人使用成人用恩赛普加强免疫5年后蜱传脑炎抗体的长期持续存在情况
Vaccine. 2009 Feb 5;27(6):853-6. doi: 10.1016/j.vaccine.2008.11.082. Epub 2008 Dec 9.
4
Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection.蜱传脑炎疫苗加强针:6 年随访结果表明长期保护效果。
Vaccine. 2009 Nov 23;27(50):7027-30. doi: 10.1016/j.vaccine.2009.09.068. Epub 2009 Sep 26.
5
Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up.蜱传脑炎加强免疫后的抗体持久性:加强免疫后3年随访
Vaccine. 2007 Jun 28;25(27):5097-101. doi: 10.1016/j.vaccine.2007.01.116. Epub 2007 Feb 20.
6
Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.在采用快速免疫程序进行初次免疫后,经过较长时间间隔对蜱传脑炎(TBE)加强免疫的反应。
Int J Med Microbiol. 2006 May;296 Suppl 40:208-12. doi: 10.1016/j.ijmm.2006.01.009. Epub 2006 Mar 10.
7
Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.首次接种Encepur儿童疫苗加强针5年后,儿童体内蜱传脑炎抗体的长期持续性。
Vaccine. 2009 Mar 4;27(10):1585-8. doi: 10.1016/j.vaccine.2008.12.057. Epub 2009 Jan 20.
8
TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?按照快速免疫程序进行蜱传脑炎加强免疫:3年的加强免疫间隔真的有必要吗?
Vaccine. 2004 Dec 2;23(3):312-5. doi: 10.1016/j.vaccine.2004.06.007.
9
Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?接种蜱传脑炎疫苗后保护性免疫的持续时间——比预期更长?
Vaccine. 2004 Jul 29;22(21-22):2743-9. doi: 10.1016/j.vaccine.2004.01.041.
10
Study of the serological response after vaccination against tick-borne encephalitis in Sweden.瑞典蜱传脑炎疫苗接种后的血清学反应研究。
Vaccine. 2007 Jan 4;25(2):366-72. doi: 10.1016/j.vaccine.2006.07.026. Epub 2006 Aug 2.

引用本文的文献

1
The inflammaging microenvironment induces dysfunctional rewiring of Tfh cell differentiation.炎性衰老微环境诱导滤泡辅助性T细胞分化的功能失调性重塑。
JCI Insight. 2025 Mar 4;10(8). doi: 10.1172/jci.insight.187271. eCollection 2025 Apr 22.
2
Tetanus Vaccination in Agricultural Workers: A Retrospective Study on Seroprevalence over 10 Years.农业工人的破伤风疫苗接种:一项关于10年血清流行率的回顾性研究。
Vaccines (Basel). 2024 Dec 2;12(12):1363. doi: 10.3390/vaccines12121363.
3
Clinical Characteristics of Tick-Borne Encephalitis in Adult Patients: A 10-year Retrospective Study in Stockholm, Sweden.
成年患者蜱传脑炎的临床特征:瑞典斯德哥尔摩的一项10年回顾性研究
J Infect Dis. 2025 Feb 4;231(1):e195-e205. doi: 10.1093/infdis/jiae463.
4
Defining the "Correlate(s) of Protection" to tick-borne encephalitis vaccination and infection - key points and outstanding questions.确定蜱传脑炎疫苗接种和感染的“保护相关因素”——要点与突出问题
Front Immunol. 2024 Jan 22;15:1352720. doi: 10.3389/fimmu.2024.1352720. eCollection 2024.
5
Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023.蜱传脑炎疫苗:美国免疫实践咨询委员会 2023 年的建议。
MMWR Recomm Rep. 2023 Nov 10;72(5):1-29. doi: 10.15585/mmwr.rr7205a1.
6
Vaccine responses in ageing and chronic viral infection.衰老与慢性病毒感染中的疫苗反应。
Oxf Open Immunol. 2021 Apr 19;2(1):iqab007. doi: 10.1093/oxfimm/iqab007. eCollection 2021.
7
A Single-Administration Microneedle Skin Patch for Multi-Burst Release of Vaccine against SARS-CoV-2.一种用于多次释放抗SARS-CoV-2疫苗的单次给药微针皮肤贴片。
Adv Mater Technol. 2022 Oct 30:2200905. doi: 10.1002/admt.202200905.
8
Cellular and humoral immune response to the fourth Pfizer-BioNTech COVID-19 vaccine dose in individuals aged 60 years and older.60 岁及以上人群对第四剂辉瑞-BioNTech COVID-19 疫苗的细胞和体液免疫反应。
Vaccine. 2023 Jan 23;41(4):914-921. doi: 10.1016/j.vaccine.2022.12.035. Epub 2022 Dec 21.
9
Vaccines and Senior Travellers.疫苗与老年旅行者
Front Aging. 2021 Jul 9;2:677907. doi: 10.3389/fragi.2021.677907. eCollection 2021.
10
A cross-sectional study evaluating tick-borne encephalitis vaccine uptake and timeliness among adults in Switzerland.一项评估瑞士成年人中蜱传脑炎疫苗接种率和及时性的横断面研究。
PLoS One. 2021 Dec 14;16(12):e0247216. doi: 10.1371/journal.pone.0247216. eCollection 2021.